PDE5A and Dyschromatopsia: However, the focus of this review will be acquired dyschromatopsia and its connection to these specific drugs: chloroquine/hydroxychloroquine (CQ/HCQ), digoxin, ethambutol (EMB), and phosphodiesterase-5 inhibitors (PDE-5 inhibitors).